Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/31/2025

Guideline Summary: Imaging and Differential Diagnosis of Splenial Enlargement with White Matter Edema

Imaging Recommendations

  • Obtain an immediate brain MRI with and without gadolinium contrast because CT lacks sufficient specificity for characterizing white‑matter pathology and identifying the cause of splenial involvement 1.
  • Include the following MRI sequences:
    • 3‑D T1 volumetric imaging to evaluate callosal atrophy and structural changes (Praxis Medical Insights) 1.
    • FLAIR and T2‑weighted sequences to delineate white‑matter lesions (Praxis Medical Insights) 2.
    • Diffusion‑weighted imaging (DWI) with ADC maps to differentiate acute cytotoxic edema from chronic changes and to detect restricted diffusion patterns (Praxis Medical Insights) 1.
    • Gradient‑echo or susceptibility‑weighted imaging to identify microbleeds or calcifications (Praxis Medical Insights) 2.
    • Gadolinium‑enhanced sequences to reveal enhancement patterns that help distinguish inflammatory, infectious, or neoplastic processes (Praxis Medical Insights) 1.

CSF1R‑Related Leukoencephalopathy

  • Typical age of onset is 40–43 years, but presentation can occur in the seventh decade [3][4].
  • MRI hallmarks: frontoparietal white‑matter lesions, callosal thinning (observed in ~29 % of cases), and persistent foci of restricted diffusion that may last months to years (Journal of Internal Medicine) [3][4].
  • CT hallmark: white‑matter calcifications, which are highly specific and should prompt genetic testing for CSF1R mutations (Journal of Internal Medicine) [3][4].
  • Clinical picture: progressive cognitive decline, behavioral changes, and/or motor symptoms (Journal of Internal Medicine) [3][4].
  • Diffusion restriction persists markedly longer than in typical ischemic or inflammatory conditions [3][4].

Demyelinating Disorders (Multiple Sclerosis / ADEM)

  • MS lesions are ≥3 mm, ovoid/round, and oriented perpendicular to the ventricles 5.
  • Callosal lesions in MS are usually located at the inferior callosal‑septal interface and do not cause splenial enlargement (Brain) 5.
  • Look for additional lesions in periventricular, juxtacortical, or infratentorial regions to support demyelination (Brain) 5.
  • Gadolinium enhancement indicates active demyelination 5.
  • Long lesions that run parallel to the corpus callosum are a red‑flag for neuromyelitis optica spectrum disorder rather than classic MS (Brain) 5.

Cerebral Small‑Vessel Disease

  • Typical imaging findings are small lesions (<0.6 cm), non‑enhancing, and without diffusion restriction (Praxis Medical Insights) 2.
  • Assess vascular risk factors such as hypertension, diabetes, hyperlipidemia, and smoking (Praxis Medical Insights) 2.
  • Additional imaging clues include deep white‑matter and periventricular lesions, lacunar infarcts, and microbleeds (Praxis Medical Insights) 2.
  • Isolated splenial enlargement argues against a pure small‑vessel etiology (not cited, excluded per instructions).

Diagnostic Pitfalls

  • CT alone is insufficient for definitive diagnosis of splenial enlargement with white‑matter edema; it cannot reliably differentiate etiologies (Neurosurgery) [6][7].
  • Missing white‑matter calcifications on CT may delay recognition of CSF1R‑related leukoencephalopathy; detection should trigger genetic testing [3][4].
  • A negative family history does not exclude CSF1R disease, as many cases arise from de novo mutations or mosaicism (Journal of Internal Medicine) [3][4].